Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement

Introduction: Acquired factor V inhibitor (AFVI) is a rare autoimmune bleeding disorder. The treatment of AFVI is challenging, and patients often require both bleeding control and inhibitor eradication. Methods: We conducted a retrospective analysis of the medical records of a 35-year-old Caucasian...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceglédi, Andrea, Dolgos, János, Fekete, Mónika, Gopcsa, László, Várkonyi, Andrea, Vilimi, Beáta, Mikala, Gábor, Bodó, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272408/
https://www.ncbi.nlm.nih.gov/pubmed/37334173
http://dx.doi.org/10.3389/pore.2023.1611250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272408/
https://www.ncbi.nlm.nih.gov/pubmed/37334173
http://dx.doi.org/10.3389/pore.2023.1611250

Ejemplares similares